Marwah, Harneet
Dewangan, Hitesh Kumar
Article History
Received: 28 November 2024
Accepted: 15 February 2025
First Online: 24 February 2025
Declarations
:
: All authors affirm that they have no affiliations or conflicts of interest with respect to the work presented.
: Pterostilbene shows promise as a targeted therapy for breast cancer, offering improved effectiveness with reduced side effects. Given the high mortality and incidence rates of breast cancer, it could provide a safer, more effective treatment option, potentially improving survival and quality of life for patients.